Ikarian Capital’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100	Closed	-$129	–	143
2024 Q4	$129	Buy	+100	New	+$129	﹤0.01%	122
2024 Q3	–	Hold	0	–	–	–	115